CLINICAL_TRIALS
trial_result
· 2016-03-21
Clinical Trial Update: Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal [Phase 2]
Summary
Phase 2 trial update on Everolimus (RAD001) for advanced renal cell carcinoma prior to nephrectomy; the study was terminated with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Linda C. Higgins | Conditions: Kidney Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-03-21